USANA Health Sciences, Inc. — Form 10-Q Summary
Period: Quarter and nine months ended September 29, 2012; comparative periods ended October 1, 2011. The supplied metadata identifies 2011 Q3, but the filing itself reports 2012 Q3.
Business context and reporting period
USANA develops and manufactures nutritional and personal-care products sold internationally through independent direct-selling Associates. At quarter-end, it reported approximately 242,000 active Associates and 64,000 active Preferred Customers. Associates accounted for 90% of product sales in the first nine months of 2012. The interim financial statements are unaudited.
Financial performance
Amounts below are in millions of dollars except per-share data. Margin figures are based on reported financial results; the filing specifically reports gross margin percentages.
| Metric | Q3 2012 | Q3 2011 | Nine months 2012 | Nine months 2011 |
|---|---|---|---|---|
| Net sales | $165.2 | $143.5 | $480.2 | $436.0 |
| Gross profit | $134.8 | $118.3 | $394.6 | $358.9 |
| Gross margin | 81.6% | 82.4% | 82.2% | 82.3% |
| Operating earnings | $24.1 | $18.8 | $70.1 | $57.2 |
| Net earnings | $17.5 | $12.4 | $48.0 | $37.6 |
| Diluted EPS | $1.18 | $0.81 | $3.19 | $2.39 |
- Quarterly sales rose 15.1% and net earnings rose 41.2% year over year. Nine-month sales rose 10.1% and net earnings rose 27.7%.
- Quarterly gross margin declined 80 basis points, mainly from higher raw-material costs and currency movements. Nine-month gross margin edged down 10 basis points.
- Associate incentives were 42.6% of quarterly sales versus 46.1% a year earlier, and 43.6% of nine-month sales versus 45.6%. SG&A was 24.4% of quarterly sales versus 23.3%, and 24.0% of nine-month sales versus 23.6%.
- Operating cash flow was $63.6 million for the first nine months, compared with $53.5 million in 2011. Capital spending was $6.8 million; financing cash outflow was $31.2 million, including $35.5 million of share repurchases. Cash increased by $26.2 million to $76.6 million.
- At September 29, cash was $76.6 million, current assets $138.7 million, current liabilities $66.8 million, and reported net working capital $71.9 million. Total stockholders’ equity was $197.0 million.
- The $60 million Bank of America facility, expiring April 2016, had no outstanding balance; USANA said it was compliant with its covenants. It also reported $1.2 million outstanding under a short-term foreign-currency credit arrangement due in November 2012.
Material changes and management commentary
- Asia Pacific sales increased 21.6% in the quarter, led by Greater China (+27.0%) and Southeast Asia/Pacific (+18.6%); North America/Europe rose 5.9%. North Asia declined 1.2%. The Philippines was a notable growth market, with sales up 73.8% in the quarter.
- Management attributed growth to more active Associates in key Asian markets, sales activity and promotions, price increases, and new-market contributions. Quarterly price increases added an estimated $5.2 million to sales; for the nine months, price increases, pre-increase buying, and a short-term promotion added an estimated $12.3 million, $11.0 million, and $3.8 million, respectively.
- Sales in Thailand, France, and Belgium, where operations began at the end of Q1 2012, contributed $2.4 million in the first nine months. Management said these markets were more consumer-focused than expected and growth could be slower than initially anticipated.
- Q3 SG&A increased $7.0 million year over year, including higher convention costs, wages and benefits, new-market costs, and sales-related fees. The nine-month SG&A increase was $12.1 million.
- The effective tax rate was 28.2% for Q3 and 31.7% for the first nine months, below prior-year rates. Management attributed the reduction to a manufacturing-deduction adjustment and, year to date, one-time benefits from restructuring Hong Kong and Singapore operations. It expected an approximately 33.5% Q4 rate and just over 32% for FY2012.
- Management said cash, operating cash flow, and available credit should fund ordinary operating and capital needs for the foreseeable future. It cautioned that adverse conditions or unusual capital needs could require financing, which might not be available on favorable terms.
- The board authorized an additional $50 million for repurchases after quarter-end. Including subsequent repurchases, $61.1 million remained authorized as of November 1, 2012; the company repurchased 0.9 million shares for $35.5 million during the first nine months.
Outlook, risks, and other notable disclosures
Management’s stated priorities were growth in Greater China, returning North America to growth, and international expansion, supported by a global marketing strategy, personalized offerings, and the Lifetime Matching Bonus introduced in Q2. The filing does not provide formal revenue or earnings guidance. Results for the nine months may not indicate full-year results.
Key disclosed risks include retaining and recruiting Associates, reliance on the network-marketing model, execution and regulatory requirements in new markets (including China), changes to the compensation plan, foreign-exchange movements, raw-material costs and availability, product and regulatory matters, competition, and dependence on information technology and key personnel. Management reported effective disclosure controls as of September 29, 2012 and no material quarter-over-quarter change in internal control over financial reporting. It reported no material change in market-risk disclosures from the 2011 Form 10-K.
Important facts for investors to verify
- How much sales growth persists after separating price increases, pre-increase purchasing, promotions, convention sales, currency effects, and new-market contributions.
- Whether active Associate growth continues, particularly in Greater China and Southeast Asia/Pacific, and whether the declines in Preferred Customers and North Asia persist.
- Whether raw-material costs, currency movements, and the Lifetime Matching Bonus continue to affect margins and incentive rates.
- The sustainability of earnings growth given the favorable tax adjustments, higher SG&A, and management’s stated tax-rate outlook.
- Subsequent share repurchases, remaining authorization, and liquidity/covenant headroom; also confirm the short-term foreign-currency borrowing’s repayment.